Ontario Cannabis Stores to Sell 3 New Products from THC BioMed
VANCOUVER, BC – THC BioMed Intl Ltd. announced that 3 new THC BioMed products are to be listed and sold through the Ontario Cannabis Stores: Dragon’s Lettuce dried cannabis, THC Kiss Cannabis Biscuits (Cocoa) and THC Kiss Cannabis Biscuits (Cinnamon.)
We are pleased to introduce Dragon’s Lettuce into Ontario. It’s our most potent sativa landrace strain. It is cultivated indoors in small batches at our facility in British Columbia. Dragon’s Lettuce has a minimum THC potency of 20%.
THC Kiss Cannabis Biscuits – Cocoa and Cinnamon
We are also excited to begin selling our latest offering, THC Kiss Cannabis Biscuits, in Ontario. These edibles come in two delicious flavours: Cocoa and Cinnamon.
THC Kiss Biscuits are infused with 10 mg of THC KISS extract, a fast-acting, full-spectrum proprietary cannabis extract invented by THC BioMed. For more information, please see the website thckiss.buzz.
All of our products are developed, grown, produced, infused and shipped from our state-of-the-art, fully integrated facility, in Beautiful British Columbia.
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
(This information is primarily sourced from THC BioMed. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
German Cannabis Policy Reform Takes Center Stage at ICBC Berlin 2023
BERLIN-- The International Cannabis Business Conference (ICBC) is gearing up for a timely and significant political discussion on cannabis policy reform in Germany. Building on the historic panel discussion held in 2021, where all major ...
Cronos Group Inc. to Cease Hemp-Based CBD Operations in the U.S. and Focus on Cash Flow and Future THC Market Entry
TORONTO-- Canadian cannabis company Cronos Group Inc. has revealed plans to discontinue its hemp-derived CBD operations in the United States by the end of the second quarter of this year. The decision is aimed at ...
Multi-State-Operators Set to Enter NY Adult-Use Market After Policy Change
NEW YORK–In an effort to stabilize New York's adult-use marijuana program, which has experienced a rocky rollout, new legislation and significant policy shifts have been proposed. One of the key changes is the potential entry ...